Cisco
CSCO
Alibaba
BABA
Disney
DIS
4
Apple
AAPL
5
Qualcomm
QCOM
US Stock MarketDetailed Quotes
LGVN Longeveron
- 1.720
- -0.060-3.37%
Close Mar 26 16:00 ET
- 1.720
- 0.0000.00%
Post 17:41 ET
25.68MMarket Cap-0.66P/E (TTM)
1.800High1.710Low79.89KVolume1.800Open1.780Pre Close138.26KTurnover0.63%Turnover RatioLossP/E (Static)14.93MShares6.40052wk High1.17P/B21.71MFloat Cap0.77152wk Low--Dividend TTM12.62MShs Float450.000Historical High--Div YieldTTM5.06%Amplitude0.770Historical Low1.730Avg Price1Lot Size
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
Longeveron Stock Forum
Breakthrough: FDA Fast-Tracks Novel Cell Therapy for Alzheimer's Treatment - Longeveron Secures Major Regulatory Win
Longeveron® Announces Positive Type B Meeting with U.S. FDA Regarding Pathway to BLA for Laromestrocel (Lomecel-BTM) in Alzheimer's Disease
Thursday, 20th March at 9:00 am
Planned single, pivotal Phase 2/3 clinical trial, if positive, acceptable for Biological License Application (BLA) submission for Alzheimer's disease
Alignment with FDA on proposed trial study design, population and endpoints
Initiation of planned pivotal Phase 2/3 clinical trial anticipated in 2H 20...
Target Price ...10
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release;...
No comment yet